metricas
covid
Clinics ERRATA
Journal Information
Vol. 68. Issue 8.
Pages 1176 (August 2013)
Vol. 68. Issue 8.
Pages 1176 (August 2013)
ERRATA
Open Access
ERRATA
Visits
846
Related content
Patrícia Abreu Ferreira da Cunha, Flavio Araujo Shinzato, Geraldine Trevisan Tecchio, Sarah La Porta Weber, Alexandre Brasil, Amaryllis Avakian
Ying Jin, Li Zhao, Fang Peng
Clinics. 2010;65:81510.1590/S1807-59322010000800014
Lal Dhar Mishra, Surya Kumar Dube, Ankit Agarwal, Sujit Kumar Pradhan
This item has received

Under a Creative Commons license
Article information
Full Text

Replace Surya Kumar Dubey

For Surya Kumar Dube

Fang Peng is the corresponding author

Page 834 (Abstract)

Replace OBJECTIVE: To compare the efficacy and tolerability of a fixed combination of 0.3% gatifloxacin and 1% prednisolone (Zypred®) versus the individual components used separately (Zypred® and Predfort®) for infection prophylaxis and inflammation control after cataract surgery with intraocular lens implantation.

For OBJECTIVE: To compare the efficacy and tolerability of a fixed combination of 0.3% gatifloxacin and 1% prednisolone (Zypred®) versus the individual components used separately (Zymar® and Predfort®) for infection prophylaxis and inflammation control after cataract surgery with intraocular lens implantation.

Page 835

Replace The aim of this study was to compare the inflammation control and infection prophylaxis after cataract surgery provided by a fixed combination of gatifloxacin 0.3% and prednisolone acetate 1% (Zypred®, Allergan®) versus the individual components (Zypred® and Predfort®).

For The aim of this study was to compare the inflammation control and infection prophylaxis after cataract surgery provided by a fixed combination of gatifloxacin 0.3% and prednisolone acetate 1% (Zypred®, Allergan®) versus the individual components (Zymar® and Predfort®).

No potential conflict of interest was reported.

Copyright © 2013. CLINICS
Download PDF
Article options
Tools